Author:
Vanalli Mariangela,Rio Francesca
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference17 articles.
1. Abbasi S, Badheeb A: Prognostic factors in advanced non-small-cell lung cancer patients: Patient characteristics and type of chemotherapy. Lung Cancer International. 2011, 0 (0): 1-4.
2. Albain KS, Crowley JJ, LeBlanc M, Livingston RB: Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. Journal of Clinical Oncology. 1991, 9: 1618-1626.
3. American Cancer Society: Cancer facts and figures. 2012, Retrieved from [
http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf
]. Accessed November 21, 2014
4. Boyd CM, Vollenweider D, Puhan MA: Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS ONE. 2012, 7: e41601-10.1371/journal.pone.0041601.
5. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016/0021-9681(87)90171-8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献